4-hydroxy-nonenal—a bioactive lipid peroxidation product

Biomolecules

Volumn 5, Issue 4, 2015, Pages 2247-2337

  Schaur, Rudolf J ^a   Siems, Werner ^b   Bresgen, Nikolaus ^c   Eckl, Peter M ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b KortexMed GmbH   (Germany)

^c UNIVERSITY OF SALZBURG   (Austria)

Author keywords

4 hydroxy nonenal; HNE; Mercapturic acid; Michael adducts; N 6 polyunsaturated fatty acids

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; ANGIOTENSIN II; ASCORBIC ACID; CARNOSINE; CARRIER PROTEIN; COLLAGEN; CYTOCHROME C; CYTOSKELETON PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTONE H2A; HYDROLASE; INSULIN; ISOMERASE; LIPID; LYASE; MEMBRANE PROTEIN; NUCLEIC ACID; OMEGA 6 FATTY ACID; OXIDOREDUCTASE; PLATELET DERIVED GROWTH FACTOR; RECEPTOR; THIOREDOXIN; TRANSFERASE; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; UNINDEXED DRUG; UNSATURATED FATTY ACID;

ACETAL AND THIO ACETAL FORMATION; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BIOPHYSICS; CHEMICAL REACTION; CHEMICAL STRUCTURE; EPOXIDATION; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; LIVER CELL; MAMMAL CELL; MASS SPECTROMETRY; METABOLITE; MICHAEL ADDITION; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REDUCTION; TARGET CELL; TISSUES; ANIMAL; METABOLISM; PHYSIOLOGY;

ACETYLCYSTEINE; ANIMALS; FATTY ACIDS, UNSATURATED; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS;

EID: 85012054817     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5042247     Document Type: Article

References (360)

1. Schauenstein, E.; Esterbauer, H. Ueber die Reaktion von 9,12 Linolsaeureester in Wasser 6. Mitteilung: Chromatographische Untersuchungen ueber die Zusammensetzung des Praeparates LHPO und die Isolierung der einzelnen tumor-wirksamen Hydroperoxid-Komponenten (In Germany). Chem. Mon. 1963, 94, 11.
2. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine, 4th ed.; Oxford University Press: Oxford, UK, 2007.
3. Catala, A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 2009, 157, 1–11.
4. Poli, G.; Schaur R.J.; Siems W.G.; Leonarduzzi, G. 4-Hydroxynonenal: A membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 2008, 28, 569–631.
5. Schaur J.R. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Asp. Med. 2003, 24, 149–159.
6. Dubinina, E.E.; Dadali, V.A. Role of 4-hydroxy-trans-2-nonenal in cell functions. Biochem. Moscow 2010, 75, 1069–1087.
7. Fritz, K.S.; Petersen, D.R. An overview of the chemistry and biology of reactive aldehydes. Free Rad. Biol. Med. 2013, 59, 85–91.
8. Zarkovic, N.; Cipak, A.; Jaganjac, M.; Borovic, S.; Zarkovic, K. Pathophysiological relevance of aldehydic protein modifications. J. Proteomics 2013, 92, 239–247.
9. Perluigi, M.; Coccia, R.; Butterfield, D.A. 4-hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: A toxic combination illuminated by redox proteomics studies. Antioxid. Redox Signal. 2012, 17, 1590–1609.
10. Riahi, Y.; Cohen, G.; Shamni, O.; Sasson, S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E879–E886.
11. Forman, H.J. Reactive oxygen species and α,β-unsaturated aldehydes as second messengers in signal transduction. Oxid. Nitrosative Stress Dis. 2010, 1203, 35–44.
12. Higdon, A.; Diers, A.R.; Oh, J.Y.; Landar, A.; Darley-Usmar, V.M. Cell signalling by reactive lipid species: New concepts and molecular mechanisms. Biochem. J. 2012, 442, 453–464.
13. Dwivedi, S.; Sharma, A.; Patrick, B.; Sharma, R.; Awasthi, Y.C. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep. 2007, 12, 4–10.
14. Ayala, A.; Munoz, M.F.; Argueelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, doi:10.1155/2014/360438.
15. Spickett, C.M. The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis. Redox Biol. 2013, 1, 145–152.
16. LoPachin, R.M.; Gavin, T.; Petersen, D.R.; Barber, D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: Nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22, 1499–1508.
17. Mattson, M.P. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp. Gerontol. 2009, 44, 625–633.
18. Guichardant, M.; Lagarde, M. Analysis of biomarkers from lipid peroxidation: A comparative study. Eur. J. Lipid Sci. Technol. 2009, 111, 75–82.
19. Tappel, A.L. Measurement and protection from in vivo lipid peroxidation. In Free Radicals in Biology; Pryor, W.A., Ed.; Academic Press: New York, NY, USA, 1980; pp. 1–47.
20. Aikens, J.; Dix, T.A. Perhydroxyl radical (HOO.) initiated lipid-peroxidation—The role of fatty-acid hydroperoxides. J. Biol. Chem. 1991, 266, 15091–15098.
21. Tsunada, S.; Iwakiri, R.; Noda, T.; Fujimoto, K.; Fuseler, J.; Rhoads, C.A.; Aw, T.Y. Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione. Dig. Dis. Sci. 2003, 48, 210–222.
22. Bochkov, V.N.; Kadl, A.; Huber, J.; Gruber, F.; Binder, B.R.; Leitinger, N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002, 419, 77–81.
23. Yin, H.; Morrow, J.D.; Porter, N.A. Identification of a novel class of endoperoxides from arachidonate autoxidation. J. Biol. Chem. 2004, 279, 3766–3776.
24. Poli, G.; Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. Iubmb Life 2000, 50, 315–321.
25. Pillon, N.J.; Soulere, L.; Vella, R.E.; Croze, M.; Care, B.R.; Soula, H.A.; Doutheau, A.; Lagarde, M.; Soulage, C.O. Quantitative structure-activity relationship for 4-hydroxy-2-alkenal induced cytotoxicity in L6 muscle cells. Chem. Biol. Interact. 2010, 188, 171–180.
26. Vazdar, M.; Jurkiewicz, P.; Hof, M.; Jungwirth, P.; Cwiklik, L. Behavior of 4-hydroxynonenal in phospholipid membranes. J. Phys. Chem. B 2012, 116, 6411–6415.
27. Dabrowski, M.J.; Zolnerciks, J.K.; Balogh, L.M.; Greene, R.J.; Kavanagh, T.J.; Atkins, W.M. Stereoselective Effects of 4-hydroxynonenal in cultured mouse hepatocytes. Chem. Res. Toxicol. 2010, 23, 1601–1607.
28. Hiratsuka, A.; Saito, H.; Watabe, T. (S)-preferential cytotoxicity of 4-hydroxy-2(E)-nonenal enantiomers in rat Clone 9 cells. Toxicology 2001, 164, 199.
29. Gueraud, F.; Crouzet, F.; Alary, J.; Rao, D.; Debrauwer, L.; Laurent, F.; Cravedi, J.P. Enantioselective metabolism of (R)- and (S)-4-hydroxy-2-nonenal in rat. Biofactors 2005, 24, 97–104.
30. Sadhukhan, S.; Han, Y.; Jin, Z.; Tochtrop, G.P.; Zhang, G.-F. Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver. Free Rad. Biol. Med. 2014, 70, 78–85.
31. Wakita, C.; Maeshima, T.; Yamazaki, A.; Shibata, T.; Ito, S.; Akagawa, M.; Ojika, M.; Yodoi, J.; Uchida, K. Stereochemical configuration of 4-hydroxy-2-nonenal-cysteine adducts and their stereoselective formation in a redox-regulated protein. J. Biol. Chem. 2009, 284, 28810–28822.
32. Komisarski, M.; Kaczmarska, Z.; Kusmierek, J.T. Practical highly enantioselective synthesis of (R)- and (S)-(E)-4-hydroxynon-2-enal. Acta Biochim. Polonica 2009, 56, 189–193.
33. Yadav, U.C.S.; Ramana, K.V. Regulation of NF-kappaB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid. Med. Cell. Longevity 2013, doi:10.1155/2013/690545.
34. Singh, S.P.; Niemczyk, M.; Zimniak, L.; Zimniak, P. Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-Hydroxynonenal (4-HNE). Aging 2009, 1, 68–80.
35. Singh, S.P.; Niemczyk, M.; Saini, D.; Awasthi, Y.C.; Zimniak, L.; Zimniak, P. Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 2008, 47, 3900–3911.
36. Schneider, C.; Brash, A.R. Monomeric and dimeric routes to formation of 4-hydroxynonenal during lipid peroxidation. Abstr. Papers Am. Chem. Soc. 2013, 246, Abstract 41-AGFD.
37. Long, E.K.; Picklo, M.J., Sr. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE. Free Rad. Biol. Med. 2010, 49, 1–8.
38. Wang, X.; Allen, T.D.; Yang, Y.; Moore, D.R.; Huycke, M.M. Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages. Cancer Prev. Res. 2013, 6, 206–216.
39. Kang, S.C.; Kim, H.-W.; Kim, K.B.; Kwack, S.J.; Ahn, I.Y.; Bae, J.Y.; Lim, S.K.; Lee, B.M. Hepatotoxicity and nephrotoxicity produced by 4-hydroxy-2-nonenal (4-HNE) following 4-week oral administration to sprague-dawley rats. J. Toxicol. Environ. Health Part A 2011, 74, 779–789.
40. Zhang, Y.; Sano, M.; Shinmura, K.; Tamaki, K.; Katsumata, Y.; Matsuhashi, T.; Morizane, S.; Ito, H.; Hishiki, T.; Endo, J.; et al. 4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. J. Mol. Cell. Cardiol. 2010, 49, 576–586.
41. Mannervik, B. Five decades with glutathione and the GSTome. J. Biol. Chem. 2012, 287, 6072–6083.
42. Balogh, L.M.; Atkins, W.M. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab. Rev. 2011, 43, 165–178.
43. Rudd, L.P.; Kabler, S.L.; Morrow, C.S.; Townsend, A.J. Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1). Chem. Biol. Interact. 2011, 194, 113–119.
44. Shireman, L.M.; Kripps, K.A.; Balogh, L.M.; Conner, K.P.; Whittington, D.; Atkins, W.M. Glutathione transferase A4-4 resists adduction by 4-hydroxynonenal. Arch. Biochem. Biophys. 2010, 504, 182–189.
45. Zhou, S.Y.; Decker, E.A. Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products. J. Agric. Food Chem. 1999, 47, 51–55.
46. Shearn, C.T.; Smathers, R.L.; Backos, D.S.; Reigan, P.; Orlicky, D.J.; Petersen, D.R. Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis. Free Rad. Biol. Med. 2013, 65, 680–692.
47. Zhu, Q.; Zheng, Z.-P.; Cheng, K.-W.; Wu, J.-J.; Zhang, S.; Tang, Y.S.; Sze, K.-H.; Chen, J.; Chen, F.; Wang, M. Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenal. Chem. Res. Toxicol. 2009, 22, 1721–1727.
48. Stevens, J.F.; Sowell, J.D.; Frei, B. Ascorbic Acid Conjugates. US Patent US20090104705A1, 2009.
49. Uchida, K. Immunochemical detection of lipid peroxidation-specific epitopes. In Biomarkers for Antioxidative Defense and Oxidative Damage; Aldini, G., Yeum, K.J., Niki, E., Russell, R.M., Eds.; Blackwell Publishing: Hoboken, NJ, USA, 2010; pp. 157–171.
50. Wakita, C.; Honda, K.; Shibata, T.; Akagawa, M.; Uchida, K. A method for detection of 4-hydroxy-2-nonenal adducts in proteins. Free Radic. Biol. Med. 2011, 51, 1–4.
51. Zhang, B.; Shi, Z.; Duncan, D.T.; Prodduturi, N.; Marnett, L.J.; Liebler, D.C. Relating protein adduction to gene expression changes: A systems approach. Mol. Biosyst. 2011, 7, 2118–2127.
52. Dick, R.A.; Kwak, M.K.; Sutter, T.R.; Kensler, T.W. Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase—A new role for leukotriene B-4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 2001, 276, 40803–40810.
53. Chen, H.J.C.; Chung, F.L. Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide. Chem. Res. Toxicol. 1996, 9, 306–312.
54. Perry, E.A.; Castellani, R.J.; Moreira, P.I.; Nunomura, A.; Lui, Q.; Harris, P.L.R.; Sayre, L.M.; Szweda, P.A.; Szweda, L.I.; Zhu, X.; et al. Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links. Free Radic. Res. 2013, 47, 507–510.
55. Singh, I.N.; Gilmer, L.K.; Miller, D.M.; Cebak, J.E.; Wang, J.A.; Hall, E.D. Phenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal. J. Cerebral Blood Flow Metab. 2013, 33, 593–599.
56. Fournet, G.; Martin, G.; Quash, G. α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: Suppressors of apoptogenic aldehyde oxidation and activators of apoptosis. Curr. Med. Chem. 2013, 20, 527–533.
57. Guo, J.-M.; Liu, A.-J.; Zang, P.; Dong, W.-Z.; Ying, L.; Wang, W.; Xu, P.; Song, X.-R.; Cai, J.; Zhang, S.-Q.; et al. ALDH2 protects against stroke by clearing 4-HNE. Cell Res. 2013, 23, 915–930.
58. Ma, H.; Guo, R.; Yu, L.; Zhang, Y.; Ren, J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: Role of autophagy paradox and toxic aldehyde. Eur. Heart J. 2011, 32, 1025–1038.
59. Muzio, G.; Maggiora, M.; Paiuzzi, E.; Oraldi, M.; Canuto, R.A. Aldehyde dehydrogenases and cell proliferation. Free Radic. Biol. Med. 2012, 52, 735–746.
60. Townsend, A.J.; Leone-Kabler, S.; Haynes, R.L.; Wu, Y.; Szweda, L.; Bunting, K.D. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem. Biol. Interact. 2001, 130–132, 261–273.
61. Black, W.; Chen, Y.; Matsumoto, A.; Thompson, D.C.; Lassen, N.; Pappa, A.; Vasiliou, V. Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 2012, 52, 1937–1944.
62. Yoval-Sanchez, B.; Rodriguez-Zavala, J.S. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. Chem. Res. Toxicol. 2012, 25, 722–729.
63. Murakami, Y.; Ohsawa, I.; Kasahara, T.; Ohta, S. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiol. Aging 2009, 30, 325–329.
64. Srivastava, S.; Vladykovskaya, E.; Barski, O.A.; Kaiserova, M.S.K.; Petrash, J.M.; Chung, S.S.; Hunt, G.; Dawn, B.; Bhatnagar, A. Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein e-null mice. Circ. Res. 2009, 105, 793–802.
65. Keith, R.J.; Haberzettl, P.; Vladykovskaya, E.; Hill, B.G.; Kaiserova, K.; Srivastava, S.; Barski, O.; Bhatnagar, A. Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts. Chem. Biol. Interact. 2009, 178, 242–249.
66. Li, D.; Ferrari, M.; Ellis, E.M. Human aldo-keto reductase AKR7A2 protects against the cytotoxicity and mutagenicity of reactive aldehydes and lowers intracellular reactive oxygen species in hamster V79-4 cells. Chem. Biol. Interact. 2012, 195, 25–34.
67. Jung, K.-A.; Kwak, M.-K. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid. Med. Cell. Longevity 2013, doi:10.1155/2013/423965.
68. Lyon, R.C.; Li, D.; McGarvie, G.; Ellis, E.M. Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 2013, 62, 113–121.
69. Zhong, L.; Liu, Z.; Yan, R.; Johnson, S.; Zhao, Y.; Fang, X.; Cao, D. Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochem. Biophys. Res. Commun. 2009, 387, 245–250.
70. Martin, H.-J.; Maser, E. Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem. Biol. Interact. 2009, 178, 145–150.
71. Endo, S.; Matsunaga, T.; Kuragano, T.; Ohno, S.; Kitade, Y.; Tajima, K.; el-Kabbani, O.; Hara, A. Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10). Arch. Biochem. Biophys. 2010, 503, 230–237.
72. Matsunaga, T.; Shinoda, Y.; Inoue, Y.; Endo, S.; el-Kabbani, O.; Hara, A. Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal. Chem. Biol. Interact. 2011, 191, 364–370.
73. Marchette, L.D.; Thompson, D.A.; Kravtsova, M.; Ngansop, T.N.; Mandal, M.N.A.; Kasus-Jacobi, A. Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. Free Radic. Biol. Med. 2010, 48, 16–25.
74. Amunom, I.; Dieter, L.J.; Tamasi, V.; Cai, J.; Conklin, D.J.; Srivastava, S.; Martin, M.V.; Guengerich, F.P.; Prough, R.A. Cytochromes p450 catalyze the reduction of α,β-unsaturated aldehydes. Chem. Res. Toxicol. 2011, 24, 1223–1230.
75. Zhang, G.-F.; Kombu, R.S.; Kasumov, T.; Han, Y.; Sadhukhan, S.; Zhang, J.; Sayre, L.M.; Ray, D.; Gibson, K.M.; Anderson, V.A., et al. Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs. J. Biol. Chem. 2009, 284, 33521–33534.
76. Berthiaume, J.M.; Li, Q.; Sadhukhan, S.; Henry, F.; Tochtrop, G.P.; Brunengraber, H.; Zhang, G. Catabolism of 4-hydroxy-2(E)-nonenal (HNE) via omega oxidation in perfused rat livers. FASEB J. 2013, 27, Abstract No. 794.15.
77. Subramaniam, R.; Roediger, F.; Jordan, B.; Mattson, M.P.; Keller, J.N.; Waeg, G.; Butterfield, D.A. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem. 1997, 69, 1161–1169.
78. Chen, J.J.; Yu, B.P. Alterations in mitochondrial-membrane fluidity by lipid-peroxidation products. Free Radic. Biol. Med. 1994, 17, 411–418.
79. Fleuranceau-Morel, P.; Barrier, L.; Fauconneau, B.; Piriou, A.; Huguet, F. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. Neurosci. Lett. 1999, 277, 91–94.
80. Liu, Q.; Ullery, J.; Zhu, J.; Liebler, D.C.; Marnett, L.J.; Zhang, B. RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenal. Mol. Biosyst. 2013, 9, 3036–3046.
81. Schreier, S.M.; Muellner, M.K.; Steinkellner, H.; Hermann, M.; Esterbauer, H.; Exner, M.; Gmeiner, B.M.K.; Kapiotis, S.; Laggner, H. Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox. Res. 2010, 17, 249–256.
82. Siems W.; Grune, T. Intracellular metabolism of 4-hydroxynonenal. Mol. Asp. Med. 2003, 24, 167–175.
83. Vila, A.; Tallman, K.A.; Jacobs, A.T.; Liebler, D.C.; Porter, N.A.; Marnett, L.J. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 2008, 21, 432–444.
84. Tallman, K.A.; Vila, A.; Porter, N.A.; Marnett, L.J. Measuring electrophile stress. Curr. Protoc. Toxicol. 2009, 11–17.
85. Chavez, J.; Chung, W.-G.; Miranda, C.L.; Singhal, M.; Stevens, J.F.; Maier, C.S. Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: Protein carbonylation is diminished by ascorbic acid. Chem. Res. Toxicol. 2010, 23, 37–47.
86. Codreanu, S.G.; Zhang, B.; Sobecki, S.M.; Billheimer, D.D.; Liebler, D.C. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol. Cell. Proteomics 2009, 8, 670–680.
87. Petersen, D.R.; Carbone, D.; Doorn, J. Hepatocellular targets of 4-hydroxy-2-nonenal modification. In Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy, 16–18 June 2006; Abstract No. 6.
88. Hussain, S.N.A.; Matar, G.; Barreiro, E.; Florian, M.; Divangahi, M.; Vassilakopoulos, T. Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290, L996–L1003.
89. Jung, T.; Engels, M.; Kaiser, B.; Grune, T. Distribution of oxidized and HNE-modified proteins in U87 cells. Biofactors 2005, 24, 165–170.
90. Carbone, D.L.; Doorn, J.A.; Kiebler, Z.; Ickes, B.R.; Petersen, D.R. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 2005, 315, 8–15.
91. Carbone, D.L.; Doorn, J.A.; Kiebler, Z.; Sampey, B.P.; Petersen, D.R. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2004, 17, 1459–1467.
92. Legards, J.F.; des Rosiers, C. Assay of 4-hydroxynonenal (HNE) adducts with various polyaminoacids (PAA) using gas chromatography-mass spectrometry (GCMS). In Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy, 16–18 June 2006.
93. Doorn, J.A.; Petersen, D.R. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 2003, 143, 93–100.
94. Isom, A.L.; Barnes, S.; Wilson, L.; Kirk, M.; Coward, L.; Darley-Usmar, V. Modification of cytochrome c by 4-hydroxy-2-nonenal: Evidence for histidine, lysine, and arginine-aldehyde adducts. J. Am. Soc. Mass Spectrom. 2004, 15, 1136–1147.
95. Liu, Z.F.; Minkler, P.E.; Sayre, L.A. Mass spectroscopic characterization of protein modification by 4-Hydroxy-2-(E)-nonenal and 4-Oxo-2-(E)-nonenal. Chem. Res. Toxicol. 2003, 16, 901–911.
96. Aldini, G.; Dalle-Donne, I.; Vistoli, G.; Facino, R.M.; Carini, M. Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J. Mass Spectrom. 2005, 40, 946–954.
97. Bennaars-Eiden, A.; Higgins, L.A.; Hertzel, A.V.; Kapphahn, R.J.; Ferrington, D.; Bernlohr, D.A. Covalent modification of epithelial fatty acid binding protein by 4-hydroxynonenal in vitro and in vivo: Evidence for a role in antioxidant biology. FASEB J. 2003, 17, Abstract No. 845.847.
98. Carbone, D.L.; Doorn, J.A.; Kiebler, Z.; Petersen, D.R. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem. Res. Toxicol. 2005, 18, 1324–1331.
99. Asselin, C.; Bouchard, B.; Tardif, J.C.; des Rosiers, C. Circulating 4-hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats. Free Radic. Biol. Med. 2006, 41, 97–105.
100. Moreau, R.; Nguyen, B.T.; Doneanu, C.E.; Hagen, T.M. Reversal by aminoguanidine of the age-related increase in glycoxidation and lipoxidation in the cardiovascular system of Fischer 344 rats. Biochem. Pharmacol. 2005, 69, 29–40.
101. Kim, C.H.; Zou, Y.N.; Kim, D.H.; Kim, N.D.; Yu, B.P.; Chung, H.Y. Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2006, 61, 332–338.
102. Petersen, D.R.; Doorn, J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol.Med. 2004, 37, 937–945.
103. Renner, A.; Sagstetter, M.R.; Harms, H.; Lange, V.; Gotz, M.E.; Elert, O. Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation. J. Heart Lung Transpl. 2005, 24, 730–736.
104. Galligan, J.J.; Smathers, R.L.; Fritz, K.S.; Epperson, L.E.; Hunter, L.E.; Petersen, D.R. Protein carbonylation in a murine model for early alcoholic liver disease. Chem. Res. Toxicol. 2012, 25, 1012–1021.
105. Aoyama, K.; Matsubara, K.; Kobayashi, S. Aging and oxidative stress in progressive supranuclear palsy. Eur. J. Neurol. 2006, 13, 89–92.
106. Grune, T. HNE-modified proteins: Formation, distribution and fate. In Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy, 2006; Abstract No. 17.
107. Carbone, D.L.; Doorn, J.A.; Petersen, D.R. 4-hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase. Free Radic. Biol. Med. 2004, 37, 1430–1439.
108. Okada, K.; Wangpoengtrakul, C.; Osawa, T.; Toyokuni, S.; Tanaka, K.; Uchida, K. 4-hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress—Identification of proteasomes as target molecules. J. Biol. Chem. 1999, 274, 23787–23793.
109. Hyun, D.H.; Lee, M.H.; Halliwell, B.; Jenner, P. Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: A mechanism contributing to neurodegeneration? J. Neurochem. 2002, 83, 360–370.
110. Bardag-Gorce, F.; Li, J.; French, B.A.; French, S.W. The effect of ethanol-induced CYP2E1 on proteasome activity: The role of 4-hydroxynonenal. Exp. Mol. Pathol. 2005, 78, 109–115.
111. Kessova, I.G.; Cederbaum, A.I. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells. J. Pharmacol. Exp. Ther. 2005, 315, 304–312.
112. Ferrington, D.A.; Kapphahn, R.J. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett. 2004, 578, 217–223.
113. Tsuchiya, Y.; Yamaguchi, M.; Chikuma, T.; Hojo, H. Degradation of glyceraldehyde-3-phosphate dehydrogenase triggered by 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal. Arch. Biochem. Biophys. 2005, 438, 217–222.
114. Xu, G.Z.; Liu, Y.H.; Sayre, L.M. Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (E)-4-hydroxy-2-nonenal. J. Org. Chem. 1999, 64, 5732–5745.
115. Zarkovic, N. Protein-aldehydic adducts as biomarkers of oxidative stress, lipid peroxidation and oxidative homeostasis. Free Radic. Res. 2009, 43, 33.
116. Wang, J.-F.; Tan, H. Oxidative protein modification of soluble N-ethylmaleimide-sensitive factor attachment protein receptors. FASEB J. 2013, 27, 890–897.
117. Gallagher, E.P.; Gardner, J.L.; Barber, D.S. Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria. Biochem. Pharmacol. 2006, 71, 1619–1628.
118. Alary, J.; Fernandez, Y.; Debrauwer, L.; Perdu, E.; Gueraud, F. Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat. Chem. Res.Toxicol. 2003, 16, 320–327.
119. Lucas, J.H.; Wheeler, D.G.; Guan, Z.; Suntres, Z.; Stokes, B.T. Effect of glutathione augmentation on lipid peroxidation after spinal cord injury. J. Neurotrauma 2002, 19, 763–775.
120. Yang, Y.S.; Sharma, R.; Sharma, A.; Awasthi, S.; Awasthi, Y.C. Lipid peroxidation and cell cycle signaling: 4-Hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim. Polonica 2003, 50, 319–336.
121. Patrick, B.; Li, J.; Jeyabal, P.V.S.; Reddy, P.; Yang, Y.S.; Sharma, R.; Sinha, M.; Luxon, B.; Zimniak, P.; Awasthi, S., et al. Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem. Biophys. Res. Commun. 2005, 334, 425–432.
122. Dwivedi, S.; Sharma, R.; Sharma, A.; Zimniak, P.; Ceci, J.D.; Awasthi, Y.C.; Boor, P.J. The course of CCl4 induced hepatotoxicity is altered in mGSTA4-4 null (−/−) mice. Toxicology 2006, 218, 58–66.
123. Engle, M.R.; Singh, S.P.; Czernik, P.J.; Gadd, D.; Montague, D.C.; Ceci, J.D.; Yang, Y.S.; Awasthi, S.; Awasthi, Y.C.; Zimniak, P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mGSTA4 null mouse. Toxicol. Appl. Pharmacol. 2004, 194, 296–308.
124. Knoll, N.; Ruhe, C.; Veeriah, S.; Sauer, J.; Glei, M.; Gallagher, E.P.; Pool-Zobel, B.L. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol. Sci. 2005, 86, 27–35.
125. Srivastava, S.; Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K. Synthesis, quantification, characterization, and signaling properties of glutathionyl conjugates of enals. Methods Enzymol. 2010, 474, 297–313.
126. Frohnert, B.I.; Long, E.K.; Hahn, W.S.; Bernlohr, D.A. Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation. Diabetes 2014, 63, 89–100.
127. Spite, M.; Summers, L.; Porter, T.F.; Srivastava, S.; Bhatnagar, A.; Serhan, C.N. Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 2009, 158, 1062–1073.
128. Aldini, G.; Facino, R.M.; Beretta, G.; Carini, M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives. Biofactors 2005, 24, 77–87.
129. Aldini, G.; Carini, M.; Beretta, G.; Bradamante, S.; Facino, R.M. Carnosine is a quencher of 4-hydroxy-nonenal: Through what mechanism of reaction? Biochem. Biophys. Res. Commun. 2002, 298, 699–706.
130. Barski, O.A.; Xie, Z.; Baba, S.P.; Sithu, S.D.; Agarwal, A.; Cai, J.; Bhatnagar, A.; Srivastava, S. Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein e-null mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 1162–1170.
131. Wang, M.; Fang, H.; Han, X. Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization. Anal. Chem. 2012, 84, 4580–4586.
132. Guiotto, A.; Calderan, A.; Ruzza, P.; Osler, A.; Rubini, C.; Jo, D.G.; Mattson, M.P.; Borin, G. Synthesis and evaluation of neuroprotective alpha,beta-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine. J. Med. Chem. 2005, 48, 6156–6161.
133. Guiotto, A.; Calderan, A.; Ruzza, P.; Borin, G. Carnosine and carnosine-related antioxidants: A review. Curr. Med. Chem. 2005, 12, 2293–2315.
134. Vistoli, G.; Orioli, M.; Pedretti, A.; Regazzoni, L.; Canevotti, R.; Negrisoli, G.; Carini, M.; Aldini, G. Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. Chemmedchem 2009, 4, 967–975.
135. Bertinaria, M.; Rolando, B.; Giorgis, M.; Montanaro, G.; Guglielmo, S.; Buonsanti, M.F.; Carabelli, V.; Gavello, D.; Daniele, P.G.; Fruttero, R., et al. Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents. J. Med. Chem. 2011, 54, 611–621.
136. Sugano, E.; Isago, H.; Murayama, N.; Tamai, M.; Tomita, H. Different anti-oxidant effects of thioredoxin 1 and thioredoxin 2 in retinal epithelial cells. Cell Struct. Funct. 2013, 38, 81–88.
137. Zhang, H.; Du, Y.; Zhang, X.; Lu, J.; Holmgren, A. Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal. Antioxid. Redox Signal. 2014, 21, 669–681.
138. Tang, X.; Sayre, L.M.; Tochtrop, G.P. A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. J. Mass Spectrom. 2011, 46, 290–297.
139. Gardner, H.W.; Deighton, N. Effect of 4-hydroxy-2(E)-nonenal on soybean lipoxygenase-1. Lipids 2001, 36, 623–628.
140. Uchida, K.; Stadtman, E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase—A possible involvement of intramolecular and intermolecular cross-linking reaction. J. Biol. Chem. 1993, 268, 6388–6393.
141. Ishii, T.; Tatsuda, E.; Kumazawa, S.; Nakayama, T.; Uchida, K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 2003, 42, 3474–3480.
142. Van Iersel, M.L.P.S.; Ploemen, J.-P.H.T.M.; lo Bello, M.; Federici, G.; van Bladeren, P.J. Interactions of α,β-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem. Biol. Interact. 1997, 108, 67–78.
143. Bosch-Morell, F.; Flohe, L.; Marin, N.; Romero, F.J. 4-Hydroxynonenal inhibits glutathione peroxidase: Protection by glutathione. Free Radic. Biol. Med. 1999, 26, 1383–1387.
144. Korotchkina, L.G.; Yang, H.S.; Tirosh, O.; Packer, L.; Patel, M.S. Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 2001, 30, 992–999.
145. Del Corso, A.; dal Monte, M.; Vilardo, P.G.; Cecconi, I.; Moschini, R.; Banditelli, S.; Cappiello, M.; Tsai, L.; Mura, U. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch. Biochem. Biophys. 1998, 350, 245–248.
146. Yu, M.K.; Moos, P.J.; Cassidy, P.; Wade, M.; Fitzpatrick, F.A. Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase—Modulation of selenoproteins by lipoxygenase enzymes. J. Biol. Chem. 2004, 279, 28028–28035.
147. Fang, J.G.; Holmgren, A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J. Am. Chem. Soc. 2006, 128, 1879–1885.
148. Chen, Z.H.; Saito, Y.; Yoshida, Y.; Sekine, A.; Noguchi, N.; Niki, E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 2005, 280, 41921–41927.
149. Chen, Z.H.; Yoshida, Y.; Saito, Y.; Noguchi, N.; Niki, E. Adaptive response induced by lipid peroxidation products in cell cultures. FEBS Lett. 2006, 580, 479–483.
150. Morquette, B.; Shi, Q.; Lavigne, P.; Ranger, P.; Fernandes, J.C.; Benderdour, M. Production of lipid peroxidation products in osteoarthritic tissues—New evidence linking 4-hydroxynonenal to cartilage degradation. Arthritis Rheum. 2006, 54, 271–281.
151. Ramanathan, R.; Mancini, R.A.; Suman, S.P.; Beach, C.M. Covalent binding of 4-hydroxy-2-nonenal to lactate dehydrogenase decreases NADH formation and metmyoglobin reducing activity. J. Agric. Food Chem. 2014, 62, 2112–2117.
152. Schlisser, A.E.; Yan, J.; Hales, B.F. Teratogen-induced oxidative stress targets glyceraldehyde-3-phosphate dehydrogenase in the organogenesis stage mouse embryo. Toxicol. Sci. 2010, 118, 686–695.
153. Markesbery, W.R.; Carney, J.M. Oxidative alterations in Alzheimer’s disease. Brain Pathol. 1999, 9, 133–146.
154. Butterfield, D.A.; Lauderback, C.M. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress1,2. Free Radic. Biol. Med. 2002, 32, 1050–1060.
155. Markesbery, W.R.; Lovell, M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol. Aging 1998, 19, 33–36.
156. Sultana, R.; Butterfield, D.A. Oxidatively modified GST and MRP1 in Alzheimer’s disease brain: Implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 2004, 29, 2215–2220.
157. Huang, Y.; Li, W.; Kong, A.-N.T. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012, 2, 1–7.
158. Balogh, L.M.; le Trong, I.; Kripps, K.A.; Shireman, L.M.; Stenkamp, R.E.; Zhang, W.; Mannervik, B.; Atkins, W.M. Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal. Biochemistry 2010, 49, 1541–1548.
159. Calamaras, T.D.; Lee, C.; Lan, F.; Ido, Y.; Siwik, D.A.; Colucci, W.S. Post-translational modification of serine/threonine kinase LKB1 via adduction of the reactive lipid species 4-hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity. J. Biol. Chem. 2012, 287, 42400–42406.
160. Shearn, C.T.; Backos, D.S.; Orlicky, D.J.; Smathers-McCullough, R.L.; Petersen, D.R. Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol. J. Biol. Chem. 2014, 289, 15449–15462.
161. Wang, C.; Weerapana, E.; Blewett, M.M.; Cravatt, B.F. A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat. Methods 2014, 11, 79–85.
162. Shearn, C.T.; Fritz, K.S.; Reigan, P.; Petersen, D.R. Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells. Biochemistry 2011, 50, 3984–3996.
163. MacDonald, M.J.; Langberg, E.C.; Tibell, A.; Sabat, G.; Kendrick, M.A.; Szweda, L.I.; Ostenson, C.G. Identification of ATP synthase as a lipid peroxide protein adduct in pancreatic islets from humans with and without type 2 Diabetes mellitus. J. Clin. Endocrinol. Metab. 2013, 98, E727–E731.
164. Guo, J.; Prokai-Tatrai, K.; Vien, N.; Rauniyar, N.; Ughy, B.; Prokai, L. Protein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria. J. Proteomics 2011, 74, 2370–2379.
165. Shearn, C.T.; Smathers, R.L.; Stewart, B.J.; Fritz, K.S.; Galligan, J.J.; Hail, N., Jr.; Petersen, D.R. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes. Mol. Pharmacol. 2011, 79, 941–952.
166. Fang, X.; Fu, Y.; Long, M.J.C.; Haegele, J.A.; Ge, E.J.; Parvez, S.; Aye, Y. Temporally controlled targeting of 4-hydroxynonenal to specific proteins in living cells. J. Am. Chem. Soc. 2013, 135, 14496–14499.
167. Los, G.V.; Encell, L.P.; McDougall, M.G.; Hartzell, D.D.; Karassina, N.; Zimprich, C.; Wood, M.G.; Learish, R.; Ohane, R.F.; Urh, M.; et al. HatoTag: A novel protein labeling technology for cell imaging and protein analysis. ACS Chem. Biol. 2008, 3, 373–382.
168. Fritz, K.S.; Galligan, J.J.; Smathers, R.L.; Roede, J.R.; Shearn, C.T.; Reigan, P.; Petersen, D.R. 4-hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem. Res. Toxicol. 2011, 24, 651–662.
169. Krohne, T.U.; Kaemmerer, E.; Holz, F.G.; Kopitz, J. Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp. Eye Res. 2010, 90, 261–266.
170. Wang, D.S.; Iwata, N.; Hama, E.; Saido, T.C.; Dickson, K. Oxidized neprilysin in aging and Alzheimer’s disease brains. Biochem. Biophys. Res. Commun. 2003, 310, 236–241.
171. Wang, R.; Wang, S.; Malter, J.S.; Wang, D.-S. Effects of HNE-modification induced by A beta on neprilysin expression and activity in SH-SY5Y cells. J. Neurochem. 2009, 108, 1072–1082.
172. Wang, R.; Malter, J.S.; Wang, D.-S. N-Acetylcysteine prevents 4-hydroxynonenal—And amyloid-β-induced modification and inactivation of neprilysin in SH-SY5Y cells. J. Alzheimers Dis. 2010, 19, 179–189.
173. Liu, Q.; Simpson, D.C.; Gronert, S. Carbonylation of mitochondrial aconitase with 4-hydroxy-2-(E)-nonenal: Localization and relative reactivity of addition sites. Biochim. Biophys. Acta Proteins Proteomics 2013, 1834, 1144–1154.
174. Zhao, Y.; Miriyala, S.; Miao, L.; Mitov, M.; Schnell, D.; Dhar, S.K.; Cai, J.; Klein, J.B.; Sultana, R.; Butterfield, D.A., et al. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic. Biol. Med. 2014, 72, 55–65.
175. Gentile, F.; Pizzimenti, S.; Arcaro, A.; Pettazzoni, P.; Minelli, R.; D’Angelo, D.; Mamone, G.; Ferranti, P.; Toaldo, C.; Cetrangolo, G., et al. Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity. Biochem. J. 2009, 422, 285–294.
176. Reed, T.T.; Pierce, W.M.; Markesbery, W.R.; Butterfield, D.A. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res. 2009, 1274, 66–76.
177. Muller, C.; Bandemer, J.; Vindis, C.; Camare, C.; Mucher, E.; Gueraud, F.; Larroque-Cardoso, P.; Bernis, C.; Auge, N.; Salvayre, R., et al. Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins. Antioxid. Redox Signal. 2013, 18, 731–742.
178. Aluise, C.D.; Rose, K.; Boiani, M.; Reyzer, M.L.; Manna, J.D.; Tallman, K.; Porter, N.A.; Marnett, L.J. Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles. Chem. Res. Toxicol. 2013, 26, 270–279.
179. Tanito, M.; Haniu, H.; Elliott, M.H.; Singh, A.K.; Matsumoto, H.; Anderson, R.E. Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration. Free Radic. Biol. Med. 2006, 41, 1847–1859.
180. Toyokuni, S.; Yamada, S.; Kashima, M.; Ihara, Y.; Yamada, Y.; Tanaka, T.; Hiai, H.; Seino, Y.; Uchida, K. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 Diabetes Mellitus. Antioxid. Redox Signal. 2000, 2, 681–685.
181. Aldini, G.; Gamberoni, L.; Orioli, M.; Beretta, G.; Regazzoni, L.; Facino, R.M.; Carini, M. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J. Mass Spectrom. 2006, 41, 1149–1161.
182. Liu, Q.; Simpson, D.C.; Gronert, S. The reactivity of human serum albumin towards trans-4-hydroxy-2-nonenal. J. Mass Spectrom. 2012, 47, 411–424.
183. Khatoon, F.; Alam, K.; Ali, A. Physicochemical and immunological studies on 4-hydroxynonenal modified HSA: Implications of protein damage by lipid peroxidation products in the etiopathogenesis of SLE. Hum. Immunol. 2012, 73, 1132–1139.
184. Xiang, W.; Weisbach, V.; Sticht, H.; Seebahn, A.; Bussmann, J.; Zimmermann, R.; Becker, C.-M. Oxidative stress-induced posttranslational modifications of human hemoglobin in erythrocytes. Arch. Biochem. Biophys. 2013, 529, 34–44.
185. Naveena, B.M.; Faustman, C.; Tatiyaborworntham, N.; Yin, S.; Ramanathan, R.; Mancini, R.A. Detection of 4-hydroxy-2-nonenal adducts of turkey and chicken myoglobins using mass spectrometry. Food Chem. 2010, 122, 836–840.
186. Smathers, R.L.; Fritz, K.S.; Galligan, J.J.; Shearn, C.T.; Reigan, P.; Marks, M.J.; Petersen, D.R. Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS ONE 2012, 7, e38459.
187. Hellberg, K.; Grimsrud, P.A.; Kruse, A.C.; Banaszak, L.J.; Ohlendorf, D.H.; Bernlohr, D.A. X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal. Protein Sci. 2010, 19, 1480–1489.
188. Stewart, B.J.; Roede, J.R.; Doorn, J.A.; Petersen, D.R. Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2009, 1791, 772–780.
189. Shao, B.; Pennathur, S.; Pagani, I.; Oda, M.N.; Witztum, J.L.; Oram, J.F.; Heinecke, J.W. Modifying apolipoprotein A–I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. J. Biol. Chem. 2010, 285, 18473–18484.
190. Zhu, X.; Tang, X.; Anderson, V.E.; Sayre, L.M. Mass spectrometric characterization of protein modification by the products of nonenzymatic oxidation of linoleic acid. Chem. Res. Toxicol. 2009, 22, 1386–1397.
191. Ou, J.J.; Zhang, Y.L.; Montine, T.J. In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases. Exp. Neurol. 2002, 175, 363–369.
192. Mattson, M.P.; Chan, S.L. Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 2003, 34, 385–397.
193. Pedersen, W.A.; Fu, W.; Keller, J.N.; Markesbery, W.R.; Appel, S.; Smith, R.G.; Kasarskis, E.; Mattson, M.P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998, 44, 819–824.
194. Lovell, M.A.; Bradley, M.A.; Fister, S.X. 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. J. Alzheimers Dis. 2012, 32, 139–146.
195. Maroteaux, L.; Campanelli, J.T.; Scheller, R.H. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 1988, 8, 2804–2815.
196. Cabin, D.E.; Shimazu, K.; Murphy, D.; Cole, N.B.; Gottschalk, W.; McIlwain, K.L.; Orrison, B.; Chen, A.; Ellis, C.E.; Paylor, R.; et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 2002, 22, 8797–8807.
197. Murphy, D.D.; Rueter, S.M.; Trojanowski, J.Q.; Lee, V.M. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 2000, 20, 3214–3220.
198. Lotharius, J.; Brundin, P. Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson’s disease. Hum. Mol. Genet. 2002, 11, 2395–2407.
199. Jomova, K.; Vondrakova, D.; Lawson, M.; Valko, M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345, 91–104.
200. Xiang, W.; Schlachetzki, J.C.M.; Helling, S.; Bussmann, J.C.; Berlinghof, M.; Schaeffer, T.E.; Marcus, K.; Winkler, J.; Klucken, J.; Becker, C.-M. Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol. Cell. Neurosci. 2013, 54, 71–83.
201. Bae, E.-J.; Ho, D.-H.; Park, E.; Jung, J.W.; Cho, K.; Hong, J.H.; Lee, H.-J.; Kim, K.P.; Lee, S.-J. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of a-synuclein. Antioxid. Redox Signal. 2013, 18, 770–783.
202. Nasstrom, T.; Fagerqvist, T.; Barbu, M.; Karlsson, M.; Nikolajeff, F.; Kasrayan, A.; Ekberg, M.; Lannfelt, L.; Ingelsson, M.; Bergstrom, J. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic. Biol. Med. 2011, 50, 428–437.
203. Shibata, N.; Inose, Y.; Toi, S.; Hiroi, A.; Yamamoto, T.; Kobayashi, M. Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy. Acta Histochem. Cytochem. 2010, 43, 69–75.
204. Hortigon-Vinagre, M.P.; Chardonnet, S.; Montigny, C.; Gutierrez-Martin, Y.; Champeil, P.; Henao, F. Inhibition by 4-hydroxynonenal (HNE) of Ca2+ transport by SERCA1a: Low concentrations of HNE open protein-mediated leaks in the membrane. Free Radic. Biol. Med. 2011, 50, 323–336.
205. Gunthorpe, M.J.; Benham, C.D.; Randall, A.; Davis, J.B. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol. Sci. 2002, 23, 183–191.
206. Kishimoto, E.; Naito, Y.; Handa, O.; Okada, H.; Mizushima, K.; Hirai, Y.; Nakabe, N.; Uchiyama, K.; Ishikawa, T.; Takagi, T., et al. Oxidative stress-induced posttranslational modification of TRPV1 expressed in esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G230–G238.
207. Vindis, C.; Escargueil-Blanc, I.; Elbaz, M.; Marcheix, B.; Grazide, M.H.; Uchida, K.; Salvayre, R.; Negre-Salvayre, A. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions—Prevention by Aldehyde Scavengers. Circ. Res. 2006, 98, 785–792
208. Kumano-Kuramochi, M.; Shimozu, Y.; Wakita, C.; Ohnishi-Kameyama, M.; Shibata, T.; Matsunaga, S.; Takano-Ishikawa, Y.; Watanabe, J.; Goto, M.; Xie, Q., et al. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem. J. 2012, 442, 171–180.
209. Kim, Y.S.; Park, Z.Y.; Kim, S.Y.; Jeong, E.; Lee, Y. Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization. Chem. Biol. Interact. 2009, 182, 59–66.
210. Liu, Q.; Smith, M.A.; Avila, J.; DeBernardis, J.; Kansal, M.; Takeda, A.; Zhu, X.W.; Nunomura, A.; Honda, K.; Moreira, P.I., et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic. Biol. Med. 2005, 38, 746–754.
211. Santa-Maria, I.; Hernandez, F.; Martin, C.P.; Avila, J.; Moreno, F.J. Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 2004, 43, 2888–2897.
212. Mendez, D.; Hernaez, M.L.; Kamali, A.N.; Diez, A.; Puyet, A.; Bautista, J.M. Differential carbonylation of cytoskeletal proteins in blood group O erythrocytes: Potential role in protection against severe malaria. Infect. Genet. Evol. 2012, 12, 1780–1787.
213. Arashiki, N.; Otsuka, Y.; Ito, D.; Yang, M.; Komatsu, T.; Sato, K.; Inaba, M. The covalent modification of spectrin in red cell membranes by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochem. Biophys. Res. Commun. 2010, 391, 1543–1547.
214. Mendez, D.; Hernaez, M.L.; Diez, A.; Puyet, A.; Bautista, J.M. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions. J. Proteome Res. 2010, 9, 5770–5781.
215. Yamashima, T. Hsp70.1 and related lysosomal factors for necrotic neuronal death. J. Neurochem. 2012, 120, 477–494.
216. Perluigi, M.; Poon, H.F.; Hensley, K.; Pierce, W.M.; Klein, J.B.; Calabrese, V.; de Marco, C.; Butterfield, D.A. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice—A model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 38, 960–968.
217. Sahara, S.; Yamashima, T. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem. Biophys. Res. Commun. 2010, 393, 806–811.
218. Connor, R.E.; Marnett, L.J.; Liebler, D.C. Protein-selective capture to analyze electrophile adduction of Hsp90 by 4-hydroxynonenal. Chem. Res. Toxicol. 2011, 24, 1275–1282.
219. Smathers, R.L.; Galligan, J.J.; Stewart, B.J.; Petersen, D.R. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem. Biol. Interact. 2011, 192, 107–112.
220. Jacobs, A.T.; Marnett, L.J. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 2010, 43, 673–683.
221. Galligan, J.J.; Fritz, K.S.; Backos, D.S.; Shearn, C.T.; Smathers, R.L.; Jiang, H.; MacLean, K.N.; Reigan, P.R.; Petersen, D.R. Oxidative stress-mediated aldehyde adduction of GRP78 in a mouse model of alcoholic liver disease: Functional independence of ATPase activity and chaperone function. Free Radic. Biol. Med. 2014, 73, 411–420.
222. Brand, M.D.; Buckingham, J.A.; Esteves, T.C.; Green, K.; Lambert, A.J.; Miwa, S.; Murphy, M.P.; Pakay, J.L.; Talbot, D.A.; Echtay, K.S. Mitochondrial superoxide and aging: Uncoupling-protein activity and superoxide production. Free Radic. 2004, 203–213.
223. Esteves, T.C.; Brand, M.D. The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. Biochim. Biophys. Acta Bioenerget. 2005, 1709, 35–44.
224. Smith, A.M.O.; Ratcliffe, R.G.; Sweetlove, L.J. Activation and function of mitochondrial uncoupling protein in plants. J. Biol. Chem. 2004, 279, 51944–51952.
225. Echtay, K.S.; Esteves, T.C.; Pakay, J.L.; Jekabsons, M.B.; Lambert, A.J.; Portero-Otin, M.; Pamplona, R.; Vidal-Puig, A.J.; Wang, S.; Roebuck, S.J., et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 2003, 22, 4103–4110.
226. Echtay, K.S.; Pakay, J.L.; Esteves, T.C.; Brand, M.D. Hydroxynonenal and uncoupling proteins: A model for protection against oxidative damage. Biofactors 2005, 24, 119–130.
227. Malingriaux, E.A.; Rupprecht, A.; Gille, L.; Jovanovic, O.; Jezek, P.; Jaburek, M.; Pohl, E.E. Fatty acids are key in 4-hydroxy-2-nonenal-mediated activation of uncoupling proteins 1 and 2. PLoS ONE 2013, 8, e77786.
228. Woyda-Ploszczyca, A.; Jarmuszkiewicz, W. Hydroxynonenal-stimulated activity of the uncoupling protein in Acanthamoeba castellanii mitochondria under phosphorylating conditions. Biol. Chem. 2013, 394, 649–658.
229. Aguirre, E.; Cadenas, S. GDP and carboxyatractylate inhibit 4-hydroxynonenal-activated proton conductance to differing degrees in mitochondria from skeletal muscle and heart. Biochim. Biophys. Acta Bioenerget. 2010, 1797, 1716–1726.
230. Jin, H.; Daly, D.S.; Marks, J.R.; Zangar, R.C. Oxidatively modified proteins as plasma biomarkers in breast cancer. Cancer Biomarkers 2013, 13, 193–200.
231. Pillon, N.J.; Vella, R.E.; Soulere, L.; Becchi, M.; Lagarde, M.; Soulage, C.O. Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal. Chem. Res.Toxicol. 2011, 24, 752–762.
232. Lee, S.H.; Takahashi, R.; Goto, T.; Oe, T. Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal. Chem. Res. Toxicol. 2010, 23, 1771–1785.
233. El-Bikai, R.; Welman, M.; Margaron, Y.; Cote, J.-F.; Macqueen, L.; Buschmann, M.D.; Fahmi, H.; Shi, Q.; Maghni, K.; Fernandes, J.C., et al. Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: Implication in osteoarthritis pathogenesis. Arthritis Res. Ther. 2010, 12, doi:10.1186/ar3173.
234. Alzolibani, A.A.; al Robaee, A.A.; al-Shobaili, H.A.; Rasheed, Z. 4-Hydroxy-2-nonenal modified histone-H2A: A possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell. Immunol. 2013, 284, 154–162.
235. Guichardant, M.; Taibi-Tronche, P.; Fay, L.B.; Lagarde, M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med. 1998, 25, 1049–1056.
236. Guo, L.; Chen, Z.; Amarnath, V.; Davies, S.S. Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation. Free Radic. Biol. Med. 2012, 53, 1226–1238.
237. Sowell, J.; Frei, B.; Stevens, J.F. Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma. (Retracted article, see Proc. Natl. Acad. Sci. USA 2007, 104, 14543–14543) Proc. Natl. Acad. Sci. USA 2004, 101, 17964–17969.
238. Sowell, J.; Frei, B.; Stevens, J.F. Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma. Proc. Natl. Acad. Sci. USA 2007, 104, 14543.
239. Miranda, C.L.; Reed, R.L.; Kuiper, H.C.; Alber, S.; Stevens, J.F. Ascorbic acid promotes detoxification and elimination of 4-hydroxy-2(E)-nonenal in human monocytic THP-1 cells. Chem. Res. Toxicol. 2009, 22, 863–874.
240. Amarnath, V.; Amarnath, K.; Davies, S.; Roberts, L.J. Pyridoxamine: An extremely potent scavenger of 1,4-dicarbonyls. Chem. Res. Toxicol. 2004, 17, 410–415.
241. Hardas, S.S.; Sultana, R.; Clark, A.M.; Beckett, T.L.; Szweda, L.I.; Murphy, M.P.; Butterfield, D.A. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol. 2013, 1, 80–85.
242. Voulgaridou, G.-P.; Anestopoulos, I.; Franco, R.; Panayiotidis, M.I.; Pappa, A. DNA damage induced by endogenous aldehydes: Current state of knowledge. Mutat. Res. Fund. Mol. Mech. Mutagen. 2011, 711, 13–27.
243. Minko, I.G.; Kozekov, I.D.; Harris, T.A.; Rizzo, C.J.; Lloyd, R.S.; Stone, M.P. Chemistry and biology of DNA containing 1,N2-deoxyguanosine adducts of the α,β-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 2009, 22, 759–778.
244. Eckl P.M.; Ortner, A.; Esterbauer, H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat. Res. Fund. Mol. Mech. Mutagen. 1993, 290, 183–192.
245. Karlhuber, G.M.; Bauer, H.C.; Eckl P.M. Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells. Mutat. Res. Fund. Mol. Mech. Mutagen. 1997, 381, 209–216.
246. Wang, H.; Kozekov, I.D.; Harris, T.M.; Rizzo, C.J. Site-specific synthesis and reactivity of oligonucleotides containing stereochemically defined 1,N2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. J. Am. Chem. Soc. 2003, 125, 5687–5700.
247. Wacker, M.; Wanek, P.; Eder, E. Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem. Biol. Interact. 2001, 137, 269–283.
248. Kozekov, I.D.; Turesky, R.J.; Alas, G.R.; Harris, C.M.; Harris, T.M.; Rizzo, C.J. Formation of deoxyguanosine cross-links from calf thymus DNA treated with acrolein and 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2010, 23, 1701–1713.
249. Huang, H.; Kozekov, I.D.; Kozekova, A.; Wang, H.; Lloyd, R.S.; Rizzo, C.J.; Stone, M.P. DNA Cross-link induced by trans-4-Hydroxynonenal. Environ. Mol. Mutagen. 2010, 51, 625–634.
250. Huang, H.; Wang, H.; Kozekova, A.; Rizzo, C.J.; Stone, M.P. Formation of a N2-dG:N2-dG carbinolamine DNA cross-link by the trans-4-Hydroxynonenal-derived (6S,8R,11S) 1,N2-dG adduct. J. Am. Chem. Soc. 2011, 133, 16101–16110.
251. Choudhury, S.; Dyba, M.; Pan, J.; Roy, R.; Chung, F.-L. Repair kinetics of acrolein- and (E)-4-hydroxy-2-nonenal-derived DNA adducts in human colon cell extracts. Mutat. Res. Fund. Mol. Mech. Mutagen. 2013, 751, 15–23.
252. Choudhury, S.; Pan, J.; Amin, S.; Chung, F.L.; Roy, R. Repair kinetics of trans-4-hydroxynonenal-induced cyclic 1,N2-propanodeoxyguanine DNA adducts by human cell nuclear extracts. Biochemistry 2004, 43, 7514–7521.
253. Winczura, A.; Zdzalik, D.; Tudek, B. Damage of DNA and proteins by major lipid peroxidation products in genome stability. Free Radic. Res. 2012, 46, 442–459.
254. Janowska, B.; Komisarski, M.; Prorok, P.; Sokolowska, B.; Kusmierek, J.; Janion, C.; Tudek, B. Nucleotide excision repair and recombination are engaged in repair of trans-4-hydroxy-2-nonenal adducts to DNA bases in Escherichia coli. Int. J. Biol. Sci. 2009, 5, 611–620.
255. Banerjee, S.; Christov, P.P.; Kozekova, A.; Rizzo, C.J.; Egli, M.; Stone, M.P. Replication bypass of the trans-4-Hydroxynonenal-derived (6S,8R,11S)-1,N2-deoxyguanosine DNA adduct by the Sulfolobus solfataricus DNA polymerase IV. Chem. Res. Toxicol. 2012, 25, 422–435.
256. Janowska, B.; Kurpios-Piec, D.; Prorok, P.; Szparecki, G.; Komisarski, M.; Kowalczyk, P.; Janion, C.; Tudek, B. Role of damage-specific DNA polymerases in M13 phage mutagenesis induced by a major lipid peroxidation product trans-4-hydroxy-2-nonenal. Mutat. Res. Fund. Mol. Mech. Mutagen. 2012, 729, 41–51.
257. Chen, H.J.C.; Gonzalez, F.J.; Shou, M.G.; Chung, F.L. 2,3-Epoxy-4-hydroxynonanal, a potential lipid peroxidation product for etheno adduct formation, is not a substrate of human epoxide hydrolase. Carcinogenesis 1998, 19, 939–943.
258. Lee, S.H.; Arora, J.A.; Oe, T.; Blair, I.A. 4-Hydroperoxy-2-nonenal-induced formation of 1,N2-etheno-2'-deoxyguanosine adducts. Chem. Res. Toxicol. 2005, 18, 780–786.
259. Wang, Y.; Millonig, G.; Nair, J.; Patsenker, E.; Stickel, F.; Mueller, S.; Bartsch, H.; Seitz, H.K. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 2009, 50, 453–461.
260. Nair, J.; Srivatanakul, P.; Haas, C.; Jedpiyawongse, A.; Khuhaprema, T.; Seitz, H.K.; Bartsch, H. High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat. Res. Fund. Mol. Mech. Mutagen. 2010, 683, 23–28.
261. Grune, T.; Muller, K.; Zollner, S.; Haseloff, R.; Blasig, I.E.; David, H.; Siems W. Evaluation of purine nucleotide loss, lipid peroxidation and ultrastructural alterations in post-hypoxic hepatocytes. J. Physiol. Lond. 1997, 498, 511–522.
262. Grune, T.; Sommerburg, O.; Petras, T.; Siems W.G. Postanoxic formation of aldehydic lipid-peroxidation products in human renal tubular cells. Free Radic. Biol. Med. 1995, 18, 21–27.
263. Blasig, I.E.; Grune, T.; Schonheit, K.; Rohde, E.; Jakstadt, M.; Haseloff, R.F.; Siems W.G. 4-hydroxynonenal, a novel indicator of lipid-peroxidation for reperfusion injury of the myocardium. Am. J. Physiol. Heart Circ. Physiol. 1995, 269, H14–H22.
264. Grune, T.; Siems W.G.; Zollner, H.; Esterbauer, H. Metabolism of 4-hydroxynonenal, a cytotoxic lipid-peroxidation product, in ehrlich mouse ascites-cells at different proliferation stages. Cancer Res. 1994, 54, 5231–5235.
265. Blasig, I.E.; Schoenheit, K.; Siems W.G. Formation of 4-hydroxyalkenals by the reperfusion-injured rat-heart. Cell. Biochem. Mol. Asp. Reperfus. Injury 1994, 723, 462–465.
266. Siems W.G.; Grune, T.; Esterbauer, H. 4-hydroxynonenal formation during ischemia and reperfusion of rat small-intestine. Life Sci. 1995, 57, 785–789.
267. Poli, G.; Dianzani, M.U.; Cheeseman, K.H.; Slater, T.F.; Lang, J.; Esterbauer, H. Separation and characterization of the aldehydic products of lipid-peroxidation stimulated by carbon-tetrachloride or adp iron in isolated rat hepatocytes and rat-liver microsomal suspensions. Biochem. J. 1985, 227, 629–638.
268. Shao, C.X.; Roberts, K.N.; Markesbery, W.R.; Scheff, S.W.; Lovell, M.A. Oxidative stress in head trauma in aging. Free Radic. Biol. Med. 2006, 41, 77–85.
269. Williams, T.I.; Lynn, B.C.; Markesbery, W.R.; Lovell, M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer’s disease. Neurobiol. Aging 2006, 27, 1094–1099.
270. Negre-Salvayre, A.; Auge, N.; Ayala, V.; Basaga, H.; Boada, J.; Brenke, R.; Chapple, S.; Cohen, G.; Feher, J.; Grune, T., et al. Pathological aspects of lipid peroxidation. Free Radic. Res. 2010, 44, 1125–1171.
271. Grune, T.; Siems W.G.; Schneider, W. Accumulation of aldehydic lipid peroxidation products during postanoxic reoxygenation of isolated rat hepatocytes. Free Radic. Biol. Med. 1993, 15, 125–132.
272. Schwarzer, E.; Muller, O.; Arese, P.; Siems W.G.; Grune, T. Increased levels of 4-hydroxynonenal in human monocytes fed with malarial pigment hemozoin—A possible clue for hemozoin toxicity. FEBS Lett. 1996, 388, 119–122.
273. Gil, L.; Siems W.; Mazurek, B.; Gross, J.; Schroeder, P.; Voss, P.; Grune, T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic. Res. 2006, 40, 495–505.
274. Selley, M.L.; Bartlett, M.R.; McGuiness, J.A.; Hapel, A.J.; Ardlie, N.G.; Lacey, M.J. Determination of the lipid-peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid-chromatography and combined capillary column gas chromatography negative-ion chemical ionization mass-spectrometry. J. Chromatogr. Biomed. Appl. 1989, 488, 329–340.
275. Schmidt, H.; Grune, T.; Muller, R.; Siems W.G.; Wauer, R.R. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr. Res. 1996, 40, 15–20.
276. Michel, P.; Eggert, W.; AlbrechtNebe, H.; Grune, T. Increased lipid peroxidation in children with autoimmune diseases. Acta Paediatr. 1997, 86, 609–612.
277. Uchida, K.; Itakura, K.; Kawakishi, S.; Hiai, H.; Toyokuni, S.; Stadtman, E.R. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 1995, 324, 241–248.
278. Yoritaka, A.; Hattori, N.; Uchida, K.; Tanaka, M.; Stadtman, E.R.; Mizuno, Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 1996, 93, 2696–2701.
279. Okamoto, K.; Toyokuni, S.; Uchida, K.; Ogawa, O.; Takenewa, J.; Kakehi, Y.; Kinoshita, H.; Hattorinakakuki, Y.; Hiai, H.; Yoshida, O. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer 1994, 58, 825–829.
280. Ando, Y.; Nyhlin, N.; Suhr, O.; Holmgren, G.; Uchida, K.; ElSahly, M.; Yamashita, T.; Terasaki, H.; Nakamura, M.; Uchino, M., et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 1997, 232, 497–502.
281. Butterfield, D.A.; Reed, T.; Perluigi, M.; de Marco, C.; Coccia, R.; Cini, C.; Sultana, R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 2006, 397, 170–173.
282. Morikawa, S.; Kurauchi, O.; Tanaka, M.; Yoneda, M.; Uchida, K.; Itakura, A.; Furugori, K.; Mizutani, S.; Tomoda, Y. Increased mitochondrial damage by lipid peroxidation in trophoblast cells of preeclamptic placentas. Biochem. Mol. Biol. Int. 1997, 41, 767–775.
283. Hamilton, R.F.; Li, L.; Eschenbacher, W.L.; Szweda, L.; Holian, A. Potential involvement of 4-hydroxynonenal in the response of human lung cells to ozone. Am. J. Physiol. Lung Cell. Mol. Physiol. 1998, 274, L8–L16.
284. Liu, X.L.; Lovell, M.A.; Lynn, B.C. Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry. Chem. Res. Toxicol. 2006, 19, 710–718.
285. Surh, J.; Kwon, H. Estimation of daily exposure to 4-hydroxy-2-alkenals in Korean foods containing n-3 and n-6 polyunsaturated fatty acids. Food Addit. Contam. 2005, 22, 701–708.
286. Ito, Y.; Kosuge, Y.; Sakikubo, T.; Horie, K.; Ishikawa, N.; Obokata, N.; Yokoyama, E.; Yamashina, K.; Yamamoto, M.; Saito, H., et al. Protective effect of S-allyl-L-cysteine, a garlic compound, on amyloid beta-protein-induced cell death in nerve growth factor-differentiated PC12 cells. Neurosci. Res. 2003, 46, 119–125.
287. Glei, M.; Hofmann, T.; Kuster, K.; Hollmann, J.; Lindhauer, M.G.; Pool-Zobel, B.L. Both wheat (Triticum aestivum) bran arabinoxylans and gut flora-mediated fermentation products protect human colon cells from genotoxic activities of 4-hydroxynonenal and hydrogen peroxide. J. Agric. Food Chem. 2006, 54, 2088–2095.
288. Loguercio, C.; Federico, A.; Tuccillo, C.; Terracciano, F.; D’Auria, M.V.; de Simone, C.; Blanco, C.D. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol. 2005, 39, 540–543.
289. Chowdhury, P.; Soulsby, M. Lipid peroxidation in rat brain is increased by simulated weightlessness and decreased by a soy-protein diet. Ann. Clin. Lab. Sci. 2002, 32, 188–192.
290. Skrzydlewska, E.; Ostrowska, J.; Farbiszewski, R.; Michalak, K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 2002, 9, 232–238.
291. Leiphon, L.J.; Picklo, M.J., Sr. Inhibition of aldehyde detoxification in CNS mitochondria by fungicides. Neurotoxicology 2007, 28, 143–149.
292. Ullrich, O.; Grune, T.; Henke, W.; Esterbauer, H.; Siems W.G. Identification of metabolic pathways of the lipid-peroxidation product 4-hydroxynonenal by mitochondria isolated from rat-kidney cortex. FEBS Lett. 1994, 352, 84–86.
293. Siems W.G.; Zollner, H.; Grune, T.; Esterbauer, H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J. Lipid Res. 1997, 38, 612–622.
294. Siems W.G.; Grune, T. High capacity of secondary antioxidative pathways in thymocytes: Rapid detoxification of 4-hydroxynonenal. Int. J. Thymol. 1998, 6, 518–529.
295. Ullrich, O.; Huser, H.; Ehrlich, W.; Grune, T. Intracellular metabolism of 4-hydroxynonenal in primary cultures of rabbit synovial fibroblasts. Free Radic. Biol. Med. 1997, 22, 1153–1157.
296. Grune, T.; Siems W.G.; Petras, T. Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal in in situ perfused rat kidney. J. Lipid Res. 1997, 38, 1660–1665.
297. Grune, T.; Siems W.; Kowalewski, J.; Zollner, H.; Esterbauer, H. Identification of metabolic pathways of the lipid-peroxidation product 4-hydroxynonenal by enterocytes of rat small-intestine. Biochem. Int. 1991, 25, 963–971.
298. Petras, T.; Siems W.G.; Grune, T. 4-hydroxynonenal is degraded to mercapturic acid conjugate in rat-kidney. Free Radic. Biol. Med. 1995, 19, 685–688.
299. Kinter, M.; Roberts, R.J. Glutathione consumption and glutathione peroxidase inactivation in fibroblast cell lines by 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 1996, 21, 457–462.
300. Esterbauer, H.; Zollner, H.; Lang, J. Metabolism of the lipid-peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 1985, 228, 363–373.
301. Fauler, G. Investigations on the Metabolism of 4-Hydroxy-Alkenals. Ph.D. Thesis, University of Graz, Graz, Austria, 1987.
302. Siems W.G.; Zollner, H.; Esterbauer, H. Metabolic pathways of lipid peroxidation product 4-hydroxynonenal in hepatocytes quantitative assessment of an antioxidative defense system. Free Radic. Biol. Med. 1990, 9, 110.
303. Schaur R.J.; Zollner, H.; Esterbauer, H. Biological effects of aldehydes with particular attention to hydroxynonenal and malondialdehyde. In Membrane Lipid Peroxidation; Vigo-Pelfrey, C., Ed.; CRC Press: Boca Raton, FL, USA, 1991; Volume 3, pp. 141–163.
304. Esterbauer, H.; Schaur R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81–128.
305. Siems W.; Grune, T.; Zollner, H.; Esterbauer, H. Formation and metabolism of the lipid peroxidation product 4-hydroxynonenal in liver and small intestine. In Free Radicals: From Basic Science to Medicine; Poli, G., Albano, E., Dianzani, M.U., Eds.; Birkhäuser Verlag: Basel, Switzerland, 1993; pp. 89–101.
306. Siems W.G.; Zollner, H.; Grune, T.; Esterbauer, H. Qualitative and quantitative-determination of metabolites of the lipid-peroxidation product 4-hydroxynonenal from hepatocytes, enterocytes and tumor-cells. Fresenius J. Anal. Chem. 1992, 343, 75–76.
307. Canuto, R.A.; Ferro, M.; Muzio, G.; Bassi, A.M.; Leonarduzzi, G.; Maggiora, M.; Adamo, D.; Poli, G.; Lindahl, R. Effects of aldehyde products of lipid peroxidation on the activity of aldehyde metabolizing enzymes in hepatomas. Adv. Exp. Med. Biol. 1993, 328, 17–25.
308. Canuto, R.A.; Muzio, G.; Maggiora, M.; Poli, G.; Biasi, F.; Dianzani, M.U.; Ferro, M.; Bassi, A.M.; Penco, S.; Marinari, U.M. Ability of different hepatoma-cells to metabolize 4-hydroxynonenal. Cell Biochem. Funct. 1993, 11, 79–86.
309. Ferro, M.; Marinari, U.M.; Poli, G.; Dianzani, M.U.; Fauler, G.; Zollner, H.; Esterbauer, H. Metabolism of 4-hydroxynonenal by the rat hepatoma-cell line MH1C1. Cell Biochem. Funct. 1988, 6, 245–250.
310. Canuto, R.A.; Muzio, G.; Bassi, A.M.; Biocca, M.E.; Poli, G.; Esterbauer, H.; Ferro, M. Metabolism of 4 hydroxynonenal in hepatoma cell lines. In Advances in Experimental Medicine and Biology, Vol. 284. Enzymology and Molecular Biology of Carbonyl Metabolism 3, Proceedings of the Fifth International Workshop, West Lafayette, IN, USA, 12–15 June 1990; Weiner, H., Wermuth, M.B., Crabb, D.W., Eds.; Plenum Press: New York, NY, USA, 1991, pp. 75–84.
311. Srivastava, S.; Conklin, D.J.; Liu, S.Q.; Prakash, N.; Boor, P.J.; Srivastava, S.K.; Bhatnagar, A. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. Atherosclerosis 2001, 158, 339–350.
312. Srivastava, S.; Chandra, A.; Wang, L.F.; Seifert, W.E.; DaGue, B.B.; Ansari, N.H.; Srivastava, S.K.; Bhatnagar, A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J. Biol. Chem. 1998, 273, 10893–10900.
313. Spitz, D.R.; Malcolm, R.R.; Roberts, R.J. Cytotoxicity and metabolism of 4-hydroxy-2-nonenal and 2-nonenal in H2O2-resistant cell-lines—Do aldehydic by-products of lipid-peroxidation contribute to oxidative stress. Biochem. J. 1990, 267, 453–459.
314. Meyer, M.J.; Mosely, D.E.; Amarnath, V.; Picklo, M.J. Metabohom of 4-hydroxy-trans-2-nonenal by central nervous system mitochondria is dependent on age and NAD(+) availability. Chem. Res. Toxicol. 2004, 17, 1272–1279.
315. Canuto, R.A.; Muzio, G.; Biocca, M.E.; Dianzani, M.U. Oxidative-metabolism of 4-hydroxy-2, 3-nonenal during diethyl-nitrosamine-induced carcinogenesis in rat-liver. Cancer Lett. 1989, 46, 7–13.
316. Chen, J.J.; Yu, B.P. Detoxification of reactive aldehydes in mitochondria: Effects of age and dietary restriction. Aging Clin. Exp. Res. 1996, 8, 334–340.
317. Honzatko, A.; Brichac, J.; Murphy, T.C.; Reberg, A.; Kubatova, A.; Smoliakova, I.P.; Picklo, M.J. Enantioselective metabolism of trans-4-hydroxy-2-nonenal by brain mitochondria. Free Radic. Biol. Med. 2005, 39, 913–924.
318. Alary, J.; Gueraud, F.; Cravedi, J.-P. Fate of 4-hydroxynonenal in vivo: Disposition and metabolic pathways. Mol. Asp. Med. 2003, 24, 177–187.
319. Alary, J.; Bravais, F.; Cravedi, J.P.; Debrauwer, L.; Rao, D.; Bories, G. Mercapturic acid conjugates as urinary end metabolites of the lipid-peroxidation product 4-hydroxy-2-nonenal in the rat. Chem. Res. Toxicol. 1995, 8, 34–39.
320. Winter, C.K.; Segall, H.J.; Jones, A.D. Distribution of trans-4-hydroxy-2-hexenal and tandem mass-spectrometric detection of its urinary mercapturic acid in the rat. Drug Metab. Dispos. 1987, 15, 608–612.
321. Alin, P.; Danielson, U.H.; Mannervik, B. 4-hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett. 1985, 179, 267–270.
322. Danielson, U.H.; Esterbauer, H.; Mannervik, B. Structure-activity-relationships of 4-hydroxyalkenals in the conjugation catalyzed by mammalian glutathione transferases. Biochem. J. 1987, 247, 707–713.
323. Mitchell, D.Y.; Petersen, D.R. The oxidation of α,β-unsaturated aldehydic products of lipid-peroxidation by rat-liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 1987, 87, 403–410.
324. Mitchell, D.Y.; Petersen, D.R. Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase mediated acetaldehyde oxidation by trans-4-hydroxy-2-nonenal. Hepatology 1991, 13, 728–734.
325. Hartley, D.P.; Ruth, J.A.; Petersen, D.R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol-dehydrogenase, aldehyde dehydrogenase, and glutathione-S-transferase. Arch. Biochem. Biophys. 1995, 316, 197–205.
326. Singhal, S.S.; Zimniak, P.; Awasthi, S.; Piper, J.T.; He, N.G.; Teng, J.I.; Petersen, D.R.; Awasthi, Y.C. Several closely-related glutathione-S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch. Biochem. Biophys. 1994, 311, 242–250.
327. Berhane, K.; Widersten, M.; Engstrom, A.; Kozarich, J.W.; Mannervik, B. Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid-peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. USA 1994, 91, 1480–1484.
328. Fukuda, A.; Nakamura, Y.; Ohigashi, H.; Osawa, T.; Uchida, K. Cellular response to the redox active lipid peroxidation products: Induction of glutathione S-transferase P by 4-hydroxy-2-nonenal. Biochem. Biophys. Res. Commun. 1997, 236, 505–509.
329. Yang, Y.Z.; Yang, Y.S.; Trent, M.B.; He, N.G.; Lick, S.D.; Zimniake, P.; Awasthi, Y.C.; Boor, P.J. Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: Possible role in human atherosclerosis. Atherosclerosis 2004, 173, 211–221.
330. Cao, Z.; Hardej, D.; Trombetta, L.D.; Li, Y. The role of chemically induced glutathione and glutathione S-transferase in protecting against 4-hydroxy-2-nonenal-mediated cytotoxicity in vascular smooth muscle cells. Cardiovas. Toxicol. 2003, 3, 165–177.
331. Kaiserova, K.; Srivastava, S.; Hoetker, J.D.; Awe, S.O.; Tang, X.L.; Cai, J.; Bhatnagar, A. Redox activation of aldose reductase in the ischemic heart. J. Biol. Chem. 2006, 281, 15110–15120.
332. Bander Jagt, D.L.; Kolb, N.S.; bander Jagt, T.J.; Chino, J.; Martinez, F.J.; Hunsaker, L.A.; Royer, R.E. Substrate specificity of human aldose reductase: Identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta 1995, 1249, 117–126.
333. Srivastava, S.K.; Ansari, N.H.; Hair, G.A.; Das, B. Aldose and aldehyde reductases in human-tissues. Biochim. Biophys. Acta 1984, 800, 220–227.
334. He, Q.; Khanna, P.; Srivastava, S.; van Kuijk, F.; Ansari, N.H. Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase. Biochem. Biophys. Res. Commun. 1998, 247, 719–722.
335. Srivastava, S.K.; Yadav, U.C.S.; Reddy, A.B.M.; Saxena, A.; Tammali, R.; Shoeb, M.; Ansari, N.H.; Bhatnagar, A.; Petrash, M.J.; Srivastava, S., et al. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem. Biol. Interact. 2011, 191, 330–338.
336. Koh, Y.H.; Park, Y.S.; Takahashi, M.; Suzuki, K.; Taniguchi, N. Aldehyde reductase gene expression by lipid peroxidation end products, MDA and HNE. Free Radic. Res. 2000, 33, 739–746.
337. Hoehn, A.; Koenig, J.; Grune, T. Protein oxidation in aging and the removal of oxidized proteins. J. Proteomics 2013, 92, 132–159.
338. Grune, T.; Davies, K.J.A. Breakdown of oxidized proteins as a part of secondary antioxidant defenses in mammalian cells. Biofactors 1997, 6, 165–172.
339. Grune, T.; Reinheckel, T.; Davies, K.J.A. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997, 11, 526–534.
340. Laurent, A.; Perdu-Durand, E.; Alary, J.; Debrauwer, L.; Cravedi, J.P. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol. Lett. 2000, 114, 203–214.
341. Alary, J.; Debrauwer, L.; Fernandez, Y.; Paris, A.; Cravedi, J.P.; Dolo, L.; Rao, D.; Bories, G. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. Chem. Res. Toxicol. 1998, 11, 1368–1376.
342. Li, Q.; Sadhukhan, S.; Berthiaume, J.M.; Ibarra, R.A.; Tang, H.; Deng, S.; Hamilton, E.; Nagy, L.E.; Tochtrop, G.P.; Zhang, G.-F. 4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by beta oxidation of fatty acids in the isolated rat heart. Free Rad. Biol. Med. 2013, 58, 35–44.
343. Kubatova, A.; Murphy, T.C.; Combs, C.; Picklo, M.J. Astrocytic biotransformation of trans-4-hydroxy-2-nonenal is dose-dependent. Chem. Res. Toxicol. 2006, 19, 844–851.
344. Alary, J.; Debrauwer, L.; Fernandez, Y.; Cravedi, J.P.; Rao, D.; Bories, G. 1,4-dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. Chem. Res. Toxicol. 1998, 11, 130–135.
345. Laurent, A.; Alary, J.; Debrauwer, L.; Cravedi, J.P. Analysis in the rat of 4-hydroxynonenal metabolites excreted in bile: Evidence of enterohepatic circulation of these byproducts of lipid peroxidation. Chem. Res. Toxicol. 1999, 12, 887–894.
346. Ji, B.; Ito, K.; Suzuki, H.; Sugiyama, Y.; Horie, T. Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal. Free Rad. Biol. Med. 2002, 33, 370–378.
347. Esterbauer, H.; Ertl, A.; Scholz, N. Reaction of cysteine with α,β-unsaturated aldehydes. Tetrahedron 1976, 32, 285–289.
348. Grune, T.; Michel, P.; Sitte, N.; Eggert, W.; AlbrechtNebe, H.; Esterbauer, H.; Siems W.G. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Rad. Biol. Med. 1997, 23, 357–360.
349. Peiro, G.; Alary, J.; Cravedi, J.P.; Rathahao, E.; Steghens, J.P.; Gueraud, F. Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation. Biofactors 2005, 24, 89–96.
350. Volkel, W.; Sicilia, T.; Pahler, A.; Gsell, W.; Tatschner, T.; Jellinger, K.; Leblhuber, F.; Riederer, P.; Lutz, W.K.; Gotz, M.E. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease. Neurochem. Int. 2006, 48, 679–686.
351. Ramana, K.V.; Bhatnagar, A.; Srivastava, S.; Yadav, U.C.; Awasthi, S.; Awasthi, Y.C.; Srivastava, S.K. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE)—Role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem. 2006, 281, 17652–17660.
352. Ramana, K.V.; Willis, M.S.; White, M.D.; Horton, J.W.; DiMaio, J.M.; Srivastava, D.; Bhatnagar, A.; Srivastava, S.K. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 2006, 114, 1838–1846.
353. Srivastava, S.; Ramana, K.V.; Tammali, R.; Srivastava, S.K.; Bhatnagar, A. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 2006, 55, 901–910.
354. Tammali, R.; Ramana, K.V.; Singhal, S.S.; Awasthi, S.; Srivastava, S.K. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res. 2006, 66, 9705–9713.
355. Ronis, M.J.J.; Butura, A.; Sampey, B.P.; Shankar, K.; Prior, R.L.; Korourian, S.; Albano, E.; Ingelman-Sundberg, M.; Petersen, D.R.; Badger, T.M. Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Rad. Biol. Med. 2005, 39, 619–630.
356. Arakawa, M.; Ushimaru, N.; Osada, N.; Oda, T.; Ishige, K.; Ito, Y. N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neurosci. Res. 2006, 55, 255–263.
357. Zheng, J.Y.; Mutcherson, R.; Helfand, S.L. Calorie restriction delays lipid oxidative damage in Drosophila melanogaster. Aging Cell 2005, 4, 209–216.
358. Lee, J.H.; Jung, K.J.; Kim, J.W.; Kim, H.J.; Yu, B.P.; Chung, H.Y. Suppression of apoptosis by calorie restriction in aged kidney. Exp. Gerontol. 2004, 39, 1361–1368.
359. Zainal, T.A.; Oberley, T.D.; Allison, D.B.; Szweda, L.I.; Weindruch, R. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J. 2000, 14, 1825–1836.
360. Shoeb, M.; Ansari, N.H.; Srivastava, S.K.; Ramana, K.V. 4-Hydroxynonenal in the pathogenesis and progression of human diseases. Curr. Med. Chem. 2014, 21, 230–237.